[go: up one dir, main page]

PL2646039T3 - Kompozycja i jej zastosowanie w leczeniu pęknięć odbytu - Google Patents

Kompozycja i jej zastosowanie w leczeniu pęknięć odbytu

Info

Publication number
PL2646039T3
PL2646039T3 PL12716670T PL12716670T PL2646039T3 PL 2646039 T3 PL2646039 T3 PL 2646039T3 PL 12716670 T PL12716670 T PL 12716670T PL 12716670 T PL12716670 T PL 12716670T PL 2646039 T3 PL2646039 T3 PL 2646039T3
Authority
PL
Poland
Prior art keywords
treatment
composition
anal fissures
fissures
anal
Prior art date
Application number
PL12716670T
Other languages
English (en)
Inventor
Filippo Bastia
Maurizio Saccomanno
Original Assignee
Thd Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2646039(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thd Spa filed Critical Thd Spa
Publication of PL2646039T3 publication Critical patent/PL2646039T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/577Malvaceae (Mallow family)
    • A61K36/5775Hibiscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12716670T 2012-01-30 2012-01-30 Kompozycja i jej zastosowanie w leczeniu pęknięć odbytu PL2646039T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades
EP12716670.0A EP2646039B1 (en) 2012-01-30 2012-01-30 A composition and use thereof in the treatment of anal rhagades

Publications (1)

Publication Number Publication Date
PL2646039T3 true PL2646039T3 (pl) 2014-10-31

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12716670T PL2646039T3 (pl) 2012-01-30 2012-01-30 Kompozycja i jej zastosowanie w leczeniu pęknięć odbytu

Country Status (23)

Country Link
US (1) US9345747B2 (pl)
EP (1) EP2646039B1 (pl)
JP (1) JP5903505B2 (pl)
KR (1) KR101599447B1 (pl)
CN (2) CN104114177A (pl)
AU (1) AU2012368815B2 (pl)
BR (1) BR112014018850A8 (pl)
CA (1) CA2863369C (pl)
DK (1) DK2646039T3 (pl)
ES (1) ES2485490T3 (pl)
HR (1) HRP20140594T1 (pl)
IL (1) IL233875A (pl)
IN (1) IN2014MN01733A (pl)
MX (1) MX336204B (pl)
PL (1) PL2646039T3 (pl)
RS (1) RS53457B (pl)
RU (1) RU2580622C2 (pl)
SA (1) SA113340239B1 (pl)
SG (1) SG11201404413UA (pl)
SI (1) SI2646039T1 (pl)
TW (1) TWI495476B (pl)
WO (1) WO2013114410A1 (pl)
ZA (1) ZA201405208B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101934169B1 (ko) 2013-12-24 2018-12-31 더 프록터 앤드 갬블 캄파니 피부 케어 활성제의 증진된 침투를 제공하는 화장 조성물 및 방법
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
EP3787654A4 (en) * 2018-05-02 2022-04-20 Montero Gida Sanayi Ve Ticaret Anonim Sirketi TOPICAL COMPOSITIONS FOR STRETCH MARKS ON THE SKIN
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
JP2001518910A (ja) * 1997-04-16 2001-10-16 ラボラトワール・セロビオロジツク(ソシエテ・アノニム) Hibiscus esculentus種子から抽出された少なくとも1つのタンパク質画分の使用及びこのような画分を含む化粧品組成物
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−1.3−1.6グルカン(アウレオバシジウム培養液)の医療、保健、福祉、食品および各種産業分野での応用
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
JP4544500B2 (ja) * 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
CA2523021C (en) * 2003-05-02 2013-06-11 Ceapro Inc. Improved extraction and purification method for cereal beta-glucan
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Also Published As

Publication number Publication date
US20140303094A1 (en) 2014-10-09
JP5903505B2 (ja) 2016-04-13
US9345747B2 (en) 2016-05-24
MX2014009244A (es) 2015-03-19
ES2485490T3 (es) 2014-08-13
KR20140127296A (ko) 2014-11-03
KR101599447B1 (ko) 2016-03-14
RU2580622C2 (ru) 2016-04-10
EP2646039A1 (en) 2013-10-09
JP2015504915A (ja) 2015-02-16
BR112014018850A8 (pt) 2017-07-11
HK1186378A1 (en) 2014-03-14
IL233875A0 (en) 2014-09-30
SG11201404413UA (en) 2014-10-30
IN2014MN01733A (pl) 2015-07-10
RU2014129391A (ru) 2016-03-27
WO2013114410A1 (en) 2013-08-08
BR112014018850A2 (pl) 2017-06-20
EP2646039B1 (en) 2014-05-14
CA2863369C (en) 2020-03-10
SI2646039T1 (sl) 2014-10-30
CN104114177A (zh) 2014-10-22
DK2646039T3 (da) 2014-08-11
TW201334787A (zh) 2013-09-01
CN109865000A (zh) 2019-06-11
CA2863369A1 (en) 2013-08-08
AU2012368815B2 (en) 2018-03-01
AU2012368815A1 (en) 2014-09-18
SA113340239B1 (ar) 2015-07-07
MX336204B (es) 2016-01-11
TWI495476B (zh) 2015-08-11
HRP20140594T1 (hr) 2014-10-24
RS53457B (sr) 2014-12-31
IL233875A (en) 2017-01-31
ZA201405208B (en) 2015-10-28

Similar Documents

Publication Publication Date Title
LTC3057969I2 (lt) Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su kit
TWI560180B (en) Substituted benzamides and methods of use thereof
PL3199024T3 (pl) Zastosowanie kompozycji cyklodekstryny i stosowne sposoby
SI3594348T1 (sl) Sestavki kratko aktivirajoče rna c/ebp alfa in postopki uporabe
ZA201507155B (en) Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
IL235401A0 (en) St2l antagonists and methods of use
PL2544682T3 (pl) Fitokannabinoidy w leczeniu glejaka
EP2950807A4 (en) COMPOSITIONS AND METHOD FOR USE IN THE TREATMENT OF METABOLISM DISEASES
ME03766B (me) Određeni amino-pirimidini, njihove kompozicije, i metode njihove upotrebe
SG11201505247TA (en) Solid solution compositions and use in cardiovascular disease
HRP20170840T1 (hr) Supstituirani ksantini i metode njihove uporabe
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
PL2903754T3 (pl) Łyżka i jej zastosowanie
FI20135537L (fi) Saostumanestoseos ja sen käyttö
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
BR112014006291A2 (pt) composição e utilização da composição
SMT201600069B (it) Composizioni comprendenti 15-hepe e metodi d’uso delle stesse
SG11201506389YA (en) IL-1β INHIBITOR COMPOSITION AND USE THEREOF
PL2646039T3 (pl) Kompozycja i jej zastosowanie w leczeniu pęknięć odbytu
BR112014026880A2 (pt) composição de sensibilização e método de uso
BR112014026397A2 (pt) composição e uso de uma composição
PL2988750T5 (pl) Zastosowanie chlorowodorku landilolu w długotrwałym leczeniu tachyarytmii
FR3007291B1 (fr) Composition cicatrisante et utlisation
HRP20190041T1 (hr) Usatci za poticanje integriranja mekog i tvrdog tkiva
EP3030635A4 (en) CONVERSION OF ALKANES TO ORGANIC COMPOUNDS OF SELENIUM AND TELLURE